A Randomized, Active-Controlled, Double-Blind, Phase 3 Study to Compare Efficacy and Safety of CT-P17 With Humira When Co-administered With Methotrexate in Patients With Moderate to Severe Active Rheumatoid Arthritis
Phase of Trial: Phase III
Latest Information Update: 10 Feb 2019
At a glance
- Drugs Adalimumab (Primary)
- Indications Rheumatoid arthritis
- Focus Registrational; Therapeutic Use
- Sponsors Celltrion
- 18 Nov 2018 Status changed from planning to recruiting.
- 20 Aug 2018 New trial record
- 07 Aug 2018 According to a Celltrion media release, the company is planning to conduct this trial in 75 sites in eight nations in European region from August 2018 and aims to complete by 2020.